Jove
Visualize
Contact Us

Related Experiment Videos

Postoperative maintenance therapy for inflammatory bowel disease.

Mario Cottone1, Ambrogio Orlando, Irene Modesto

  • 1Department of General Medicine, Pneumology and Nutrition Clinic, Palermo University, Palermo, Italy.

Current Opinion in Gastroenterology
|June 9, 2006
PubMed
Summary

For Crohn's disease patients, quitting smoking is the only proven method to prevent relapse after surgery. Other treatments like probiotics and enteral nutrition require further research for effectiveness in postoperative maintenance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE Study.

Advances in therapy·2026
Same author

Induction and Prolonged Induction With Mirikizumab in Ulcerative Colitis-A Prospective, Real-World Study From the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).

United European gastroenterology journal·2026
Same author

The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results From the Phase II GLADIATOR Trial.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068].

Autoimmunity reviews·2026
Same author

Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care.

Autoimmunity reviews·2026
Same author

Evaluating the correlation between fecal and serum calprotectin in inflammatory bowel disease.

Scientific reports·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Gastroenterology
  • Surgical Gastroenterology
  • Pharmacology

Background:

  • Inflammatory bowel diseases (IBD) management often requires surgical intervention.
  • Postoperative maintenance treatment is crucial for preventing disease recurrence and improving patient outcomes.
  • Research in 2005 focused on evaluating various strategies for IBD postoperative care.

Purpose of the Study:

  • To review and synthesize knowledge from 2005 studies on maintenance treatment following surgery for inflammatory bowel diseases.
  • To assess the efficacy of different interventions in preventing postoperative recurrence in Crohn's disease and ulcerative colitis.

Main Methods:

  • Literature review of studies published in 2005 concerning postoperative maintenance therapy for IBD.
  • Analysis of clinical trials, retrospective studies, and pathophysiological research.

Related Experiment Videos

  • Evaluation of evidence for smoking cessation, pharmacological agents, probiotics, and nutritional support.

    • Main Results:

    • Smoking cessation confirmed as the sole effective measure against Crohn's disease relapse post-surgery.
    • Ornidazole showed promise in reducing endoscopic recurrence and clinical relapse.
    • Probiotics (e.g., Lactobacillus johnsonii) demonstrated ineffectiveness in preventing recurrence; however, they showed potential in pouchitis.
    • Enteral nutrition suggested as a potential therapy for reducing clinical relapse, warranting further investigation.
    • Mesalamine remains a widely studied agent, with extensive trial data available.

    Conclusions:

    • Postoperative maintenance treatment for Crohn's disease remains challenging, with limited effective options beyond smoking cessation.
    • Further well-designed trials are needed for azathioprine and 6-mercaptopurine.
    • Enteral nutrition presents a promising avenue for future research in postoperative IBD management.
    • Evidence does not support probiotics for preventing recurrence, but they may benefit pouchitis.